KLF5 and cancer: Furthermore, based on our analysis of DepMap data, targeting KLF4 in ARID1A-deficient cancer cells does not appear to influence the fitness of ARID1A mutant cell lines, further highlighting the specificity of the effect of loss of KLF5 on ARID1A -deficient cells.